This article is more than 5 years old. Information may no longer be current.
Glaucoma device suggested for use in mild cases
NEW YORK — Trabectome surgery is a reasonable approach in patients with mild glaucoma, a speaker said here.
"We would recommend it for patients with high preoperative IOP or a target IOP of more than 21 mm Hg," Yachna Ahuja, MD, said at the American Glaucoma Society annual meeting.
A chart review of 246 patients looked at success outcomes of Trabectome (NeoMedix) surgery in a single-center, single-surgeon series. Patients were included, regardless of glaucoma surgery history, if they had open-angle glaucoma and were on maximum glaucoma medication.
The determined success rates depended on the stringency of the measurement criteria, Dr. Ahuja said.
Using less stringent criteria, that is, postop IOP of 21 mm Hg or less or a 20% reduction of IOP, Dr. Ahuja considered the Trabectome surgery to be successful. Results were best when Trabectome surgery was combined with cataract extraction, which happened in 158 cases. Using these less stringent criteria at 3 years after surgery, Trabectome surgery was successful in 71% of patients whose surgery was combined with cataract extraction, whereas surgery was successful in 33% of patients who underwent Trabectome alone.
Using more stringent criteria, that is, postoperative IOP of 18 mm Hg or less or a 20% reduction in IOP, success rates were much lower.
- Disclosure: Dr. Ahuja has no relevant financial disclosures.
